leftbrainmarketing.net
  • Vetted
  • Email Marketing
    • How to Write Email
    • Email Marketing Basics
    • Email Marketing Careers
    • Email Marketing Agencies
    • Email Marketing Tools & Platforms
    • Email Marketing Tools & Resources
    • Email Marketing Experts
    • Email Automation
    • Email Marketing Locations
  • Strategy and Mastery
    • Industry-Specific Email Marketing
    • Marketing
    • Target Audience Email Marketing
  • Strategy and Mastery
  • About
    • Our Team – LeftBrainMarketing
    • LeftBrainMarketing Branding Guide
    • Branding – LeftBrainMarketing
    • Vision – LeftBrainMarketing: Shaping the Future with AI in Marketing
    • Contact Us – LeftBrainMarketing
leftbrainmarketing.net
  • Vetted
  • Email Marketing
    • How to Write Email
    • Email Marketing Basics
    • Email Marketing Careers
    • Email Marketing Agencies
    • Email Marketing Tools & Platforms
    • Email Marketing Tools & Resources
    • Email Marketing Experts
    • Email Automation
    • Email Marketing Locations
  • Strategy and Mastery
    • Industry-Specific Email Marketing
    • Marketing
    • Target Audience Email Marketing
  • Strategy and Mastery
  • About
    • Our Team – LeftBrainMarketing
    • LeftBrainMarketing Branding Guide
    • Branding – LeftBrainMarketing
    • Vision – LeftBrainMarketing: Shaping the Future with AI in Marketing
    • Contact Us – LeftBrainMarketing

Browsing Category

Healthcare operations

13 posts
  • Healthcare operations

How To Make The Most Of Daily Postpartum Check-ins At Home

How To Make The Most Of Daily Postpartum Check-ins At Home
Guidance on how first-time mothers can effectively utilize daily postpartum check-ins during the first two weeks after discharge to improve recovery and safety.
  • Thorsten Meyer
  • 19. July 2026
View Post
  • Healthcare operations

4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population

4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population
4DMT announces favorable 2-year data from its PRISM Phase 2b trial targeting wet AMD, showing promising efficacy and safety outcomes.
  • leftbrainmarketing Team
  • 19. July 2026
View Post
  • Healthcare operations

Lynk Pharmaceuticals Announces Completion Of Patient Enrollment In Phase III Clinical Trial Of Zemprocitinib For Ankylosing Spondylitis

Lynk Pharmaceuticals Announces Completion Of Patient Enrollment In Phase III Clinical Trial Of Zemprocitinib For Ankylosing Spondylitis
Lynk Pharmaceuticals has finished enrolling patients in its Phase III clinical trial for Zemprocitinib targeting ankylosing spondylitis, marking a key milestone.
  • leftbrainmarketing Team
  • 15. July 2026
View Post
  • Healthcare operations

Women’s Health Radar

Women's Health Radar
A new digital tool aims to identify perimenopausal symptoms early in women aged 40-58, enabling timely care and reducing health and work disruptions.
  • Thorsten Meyer
  • 7. July 2026
View Post
  • Healthcare operations

Retirement Care Planner

Retirement Care Planner
A new retirement care planning tool is being tested to help adult children coordinate care and finances for aging parents amid rising costs and complexity.
  • Thorsten Meyer
  • 4. July 2026
View Post
  • Healthcare operations

Voluntary Recall Of Two Lots Of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food Due To Potential Fraudulent Distribution Of Product Which May Contain Foreign Material

Voluntary Recall Of Two Lots Of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food Due To Potential Fraudulent Distribution Of Product Which May Contain Foreign Material
Pedigree® has voluntarily recalled two lots of its Can High Protein Chopped Chicken & Duck Flavor due to potential foreign material contamination.
  • leftbrainmarketing Team
  • 3. July 2026
View Post
  • Healthcare operations

Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)

Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
Partner Therapeutics announced the publication of the eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma, detailed in the Journal of Clinical Oncology.
  • leftbrainmarketing Team
  • 2. July 2026
View Post
  • Healthcare operations

AI compliance brief generator for small clinics

AI compliance brief generator for small clinics
Small clinics are set to test an AI-powered compliance brief generator designed to streamline regulatory updates and operational workflows.
  • Thorsten Meyer
  • 2. July 2026
View Post
  • Healthcare operations

Vertigo relief app

Vertigo relief app
A new vertigo relief app aims to help adults with BPPV perform repositioning maneuvers at home, with potential clinical integration and market growth.
  • Thorsten Meyer
  • 1. July 2026
View Post
  • Healthcare operations

Vertigo relief app

Vertigo relief app
A new mobile app aims to assist adults with recurrent vertigo and ENT clinics by guiding home repositioning maneuvers, with testing planned soon.
  • Thorsten Meyer
  • 1. July 2026
View Post
AI's Rapid Gate Closures: A New Global Pre-Release Regime Is Emerging
  • AI & Tooling

AI’s Rapid Gate Closures: A New Global Pre-Release Regime Is Emerging

Major AI jurisdictions are implementing new pre-release gate systems, with China, the…
  • leftbrainmarketing Team
  • 19. July 2026
Best AI Marketing Automation Platforms To Watch In 2026
  • AI & Tooling

Best AI Marketing Automation Platforms To Watch In 2026

Discover the leading AI marketing automation platforms for 2026, their features, and…
  • leftbrainmarketing Team
  • 19. July 2026
How The 24% Rule Highlights Flaws In AI Cloud Sovereignty Testing
  • Security & Privacy

How The 24% Rule Highlights Flaws In AI Cloud Sovereignty Testing

The 24% ownership rule in France's SecNumCloud exposes limitations in assessing legal…
  • leftbrainmarketing Team
  • 19. July 2026
AI In 2026: 8 Breakthroughs You Can't Ignore
  • Monitor & Display Technology

AI In 2026: 8 Breakthroughs You Can’t Ignore

Discover the eight most significant AI advancements in 2026, their impact, and what…
  • leftbrainmarketing Team
  • 19. July 2026
leftbrainmarketing.net
  • blog
  • Privacy Policy
  • Website Terms and Conditions of Use
  • Impressum
  • Sitemap
Copyright © 2026 leftbrainmarketing.net Content on leftbrainmarketing.net is created and published using artificial intelligence (AI) for general informational and educational purposes. Affiliate disclaimer As an affiliate, we may earn a commission from qualifying purchases. We get commissions for purchases made through links on this website from Amazon and other third parties.